- Vouliez-vous dire
- manufacturer
Résultats de la recherche - 18 results
Chromatographic fingerprint development for the detection of tobacco varieties in commercial tobacco products
Products Abstract: Background: Manufacturers of tobacco products in Belgium are legally required to register the exact composition of their products. In the context of this bachelor’s thesis, ...
Release of Nano-objects, their aggregates and agglomerates from Masks (RENAAME): validation of a screening method to identify Ti and Ag elements in masks
the manufacture of masks and for evaluating the release of nanoparticles in the aerosol phase. This communication details the results of the first phase of the project, which aims to develop and ...
Pyrogen testing of phage therapeutic products
this work, we discuss and compare the applicability of the LAL, rFC and MAT tests for pyrogen testing of clinical grade phage products based on the analysis of various productions manufactured by the ...
Manufacture and control of vaccine adjuvants from OMCL perspective
Publication Type: Scientific poster, presentation or proceeding Authors: L. Tesolin Source: Seminaire ULB Pharmacien d'industrie, ULB, ULB pharmacie (2022) Keywords: Adjuvants manufacture OMCL ...
The GEONs API-fingerprint program: Tackling falsifications of APIs
Official Medicines Control Laboratory (OMCL) Network (GEON) different initiatives were taken to augment the analysis and market surveillance of API s used by the different manufacturers. Despite the efforts, ...
Controlled Human Infection Studies: Proposals for guidance on how to design, develop and produce a challenge strain.
Pieter Source: Biologicals, Volume 74 (2021) Abstract: There is an increasing need to establish quality principles for designing, developing and manufacturing challenge agents as currently these agents are ...
Development of a multiplex immunoassay for simultaneous detection of antigens in DTaP vaccines
antigens present in the formulation) to monitor the consistency of antigen quantity and quality throughout the production process of DT aP vaccines from two manufacturers (coded HuA and HuB). A first work ...
Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019.
exposure studies need to be safe and results should be meaningful, e.g. contribute to a better cure. Both in the US and in Europe, the level of Good Manufacturing Practice required is related to the phase of ...
Development and validation of chromatographic methods for screening and subsequent quantification of suspected illegal antimicrobial drugs encountered on the Belgian market.
amount of this molecule (in one sample only 14% of the claimed dosage was found). These quality issues might be attributed to either poor manufacturing, storage or transportation conditions. Health ...
Development and validation of chromatographic methods for screening and subsequent quantification of suspected illegal antimicrobial drugs encountered on the Belgian market
attributed to either poor manufacturing, storage or transportation conditions. Health Topics: Effectiveness and safety of vaccines, medicines and health products- Quality of medical laboratories Efficacité et ...